¹⁸F-Florbetaben and PET/CT Holds Promise for the Identification and Differentiation Among Cardiac Amyloidosis Entities

JACC Cardiovasc Imaging. 2021 Jan;14(1):256-258. doi: 10.1016/j.jcmg.2020.06.017. Epub 2020 Aug 5.

Authors

Thomas H Schindler¹, Vijay Sharma², Alessio Imperiale³

Affiliations

¹ Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA. Electronic address: [email protected].
² Division of Nuclear Medicine, Mallinckrodt Institute of Radiology, Washington University in St. Louis School of Medicine, St. Louis, Missouri, USA.
³ Biophysics and Nuclear Medicine, University Hospitals of Strasbourg, Strasbourg, France.

PMID: 32771579
DOI: 10.1016/j.jcmg.2020.06.017

No abstract available

Keywords: (18)F-florbetaben; cardiac amyloidosis; light chain; positron emission tomography; transthyretin protein.

Publication types

Editorial
Comment

MeSH terms

Amyloid Neuropathies, Familial
Aniline Compounds
Diagnosis, Differential
Humans
Immunoglobulin Light Chains*
Positron Emission Tomography Computed Tomography*
Predictive Value of Tests
Stilbenes

Substances

Aniline Compounds
Immunoglobulin Light Chains
Stilbenes
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene

Supplementary concepts

Amyloidosis, Hereditary, Transthyretin-Related